Our discoveries have been supported by European Institutions. Over the past years, our company has been recognized for our innovation with a variety of national and international awards.
EU Fast Track to Innovation
Clinical validation and production scale up of a novel product for healing of Pressure Ulcers, Leg Ulcers and Diabetic Foot Ulcers.
One of very few companies in the EU to receive SME phase 2 and FTI: Production scale and further clinical studies.
A novel bio-material is to dramatically decrease the cost of treatment of severe wounds and burns.
Awards for a 3D product for deep wounds, bioprinting and scaffolds.
EU Horizon 2020 SME phase 1 award
Novel Biomaterial for improved and cost-efficient wound healing
Success rate < 10%
Business model awarded for a novel wound healing product.
UK Wound Care Award
Biovotec Asked by NIHR WoundTec HTC To Present At The World Extreme Medicine Expo In London UK.